What is Invivyd Inc.?
, together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 133.39M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 10228,024 shares $177k | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 10227,172 shares $354k | 0 |